We should be happy that the physical weight of goods we produce, per dollar of GDP, is declining.
America’s new trade deal with Korea shows that bilateral negotiations can work. But the deal is headed for tough scrutiny on both sides of the Pacific.
European economies face the soft bigotry of low expectations.
When Chris Cox became chairman of the SEC, the Washington and Wall Street smart guys were sure what he would do. Instead, he fooled them by acting like…well, like Chris Cox.
A real disagreement about the appropriate role of art.
Some of the lawyers who committed massive fraud are finally being brought to justice.
Kevin Sharer of Amgen, the world’s largest biotech firm, talks about threats and encouragements to developing the best pharmaceuticals.
A new book chronicles how savvy objectivity took the Boston Red Sox to the top.
The Court’s latest ruling could prove very costly.
Old comic books have been among the best-performing collectibles, whipping coins, antiques, and violins. Analyzing prospects for supply and demand, Kevin Hassett asks whether the future for superheroes will be as fantastic as the past.
A surprising new study on heart disease treatments won’t just change medicine—it will help shape basic science.
Kate Bundorf is a doctor with an unusual patient: America’s healthcare economy.
Persians have been at odds with the West and neighboring Asians since the battle of Thermopylae. Today’s nuclear showdown is history repeating itself. Classicist Victor Davis Hanson tells what we can learn.
As the EU celebrates its fiftieth birthday, a trenchant new study of the continent’s economic history shows that reforms are needed.
The real reasons to oppose the new museum are artistic, not political.
Those are the antique symbols of record-keeping in today’s healthcare industry, the last to resist the revolution in information technology. The backwardness is costing billions and killing thousands, writes Newt Gingrich. Now, companies like Wal-Mart and Intel aren’t waiting for the government, and things, at last, are changing.
The Michelin Guide, published by a French tire company since 1900 and for decades the European gourmet’s bible, has invaded America, with lots of controversy but surprisingly good results, writes Amy Cortese. New York, for instance, beats Rome.
Policymakers used to think nothing could keep ex-convicts from returning to prison. Welfare reform changed that.
It’s America’s largest and most endangered health insurance program. Changes that give consumers more say—like the new Part D drug benefit—are helpful, but we’ll have to make tough trade-offs in the years ahead.